Safety, Tolerability, and Immunogenicity of TETRALITE, a Novel Adjuvanted, Low-dose Influenza Vaccin
Clinical trial NCT05581407 · COMPLETED
Trial details
- NCT number
- NCT05581407
- Sponsor
- LiteVax BV
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-03
- Primary completion
- 2023-08-03
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.